Local institution

San Francisco, California 94158

0 studies enrolling now · 20 studies all time

What they study most

AIDS, Breast Cancer, Cancer, Chronic Disease, Chronic Genotype 1 Hepatitis C Virus Infection, Chronic Hepatitis B, Congestive Heart Failure, HIV Infections, Hepatitis B, Leukemia, Melanoma, Metastases

Studies at this site

• Pan Tumor Rollover Study — Recruiting now
• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants — Withdrawn before enrolling
• Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
• A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer — Withdrawn before enrolling
• Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase — Withdrawn before enrolling
• A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma — Completed
• Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
• A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1 — Completed
• A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis — Completed
• DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy — Completed
• A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen — Completed
• Atazanavir for HIV Infected Individuals: An Early Access Program — NO_LONGER_AVAILABLE
• A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen — Completed
• The Study of Abatacept in Combination With Etanercept — Completed
• Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection — Completed
• Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen — Completed
• A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen — Completed
• Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir — Completed
• A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy — Stopped early